Evidence map›Paper›PMID 37101813›Full record

ArticleACS bio & med chem Au2023

Characterization of a Class A β-Lactamase from

Sourya Bhattacharya, Vivek Junghare, Mousumi Hazra, Niteesh Kumar Pandey, Abirlal Mukherjee, Kunal Dhankhar, Neeladrisingha Das, Partha Roy, Ramesh Chandra Dubey, Saugata Hazra

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS bio & med chem Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sourya BhattacharyaDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Vivek JunghareDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.ORCID https://orcid.org/0000-0002-7952-2092
Mousumi HazraDepartment of Botany and Microbiology, Gurukula Kangri (Deemed to be University), Haridwar 249404, Uttarakhand, India.ORCID https://orcid.org/0000-0001-5791-7993
Niteesh Kumar PandeyDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Abirlal MukherjeeDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Kunal DhankharDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Neeladrisingha DasDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Partha RoyDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Ramesh Chandra DubeyDepartment of Botany and Microbiology, Gurukula Kangri (Deemed to be University), Haridwar 249404, Uttarakhand, India.
Saugata HazraDepartment of Bioscience and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.ORCID https://orcid.org/0000-0002-3074-1534
Indian Institute of Technology Roorkee · INGurukul Kangri Vishwavidyalaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-lactamase production with vast catalytic divergence in the pathogenic strain limits the antibiotic spectrum in the clinical environment. Class A carbapenemase shares significant sequence similarities, structural features, and common catalytic mechanisms although their resistance spectrum differs from class A β-lactamase in carbapenem and monobactam hydrolysis. In other words, it limited the antibiotic treatment option against infection, causing carbapenemase-producing superbugs. Ftu-1 is a class A β-lactamase expressed by the

Identifiers

PMID37101813
PMCPMC10125328
OpenAlexW4319594471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.